"This approval signals a new era in the treatment of prostate cancer, representing a shift toward more targeted, early intervention," said Prostate Cancer Foundation Chief Executive Gina Carithers.
Scientists used CRISPR to make prostate cancer cells easier for the immune system to detect and destroy. The experimental ...
An NHS trial over 10 years followed nearly 3,500 men who received focal therapy, a less invasive treatment.
3d
Inside the FDA’s Push to Update Testosterone Therapy Labels on Prostate Cancer and Blood Pressure
Federal regulators are moving to rewrite the rulebook on testosterone replacement therapy, easing warnings that have shaped ...
President Joe Biden recently gave an update on his treatment for metastatic prostate cancer. A urologist explains ways to ...
Half a million men affected by prostate cancer will be asked to share their medical records in an NHS drive to improve early ...
Follow-up overall survival, months, median (range) 96 (15-120) Follow-up PSA to recurrence or death, months, median (range) 55 (11-111) Follow-up PSA patients alive and recurrence-free, months, median ...
"The nurse, as I was leaving - I was literally opening the door - said 'oh by the way, and you do know you have prostate ...
MRI T staging matched DRE for predicting prostate cancer outcomes, supporting its use in modern risk classification systems.
Prostate cancer is a common form of cancer that affects males. The CyberKnife is a device that uses radiation therapy that can help treat prostate cancer. CyberKnife is the brand name for a system of ...
Chris Holmes announced having been diagnosed with prostate cancer, years after having successfully treated throat and neck ...
Taiwan is considering expanding National Health Insurance to cover the full cost of prostate cancer screening, Minister of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results